The results revealed that cessation of CCL2 neutralizing antibody caused a more repaid recurrence of HNSCC compared to the cessation of CCR4 antagonist (Fig. 5B–D). The gene discussed is CCR4; the disease is head and neck squamous cell carcinoma.